These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7050045)

  • 1. Structure-cytotoxicity relationships of nitroimidazoles in an in vitro system.
    Edwards DI; Knox RJ; Knight RC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):791-3. PubMed ID: 7050045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of nitroimidazole drugs with DNA in vitro: structure-activity relationships.
    Knox RJ; Knight RC; Edwards DI
    Br J Cancer; 1981 Nov; 44(5):741-5. PubMed ID: 7032569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of nitroimidazole damage to DNA: coulometric evidence.
    Knox RJ; Edwards DI; Knight RC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1315-8. PubMed ID: 6381431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cytotoxicity of nitroimidazole drugs.
    Edwards DI
    Prog Med Chem; 1981; 18():87-116. PubMed ID: 7045984
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA damage induced by reductively activated nitroimidazoles--pH effects.
    Edwards DI; Knight RC; Zahoor A
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1207-9. PubMed ID: 3528090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base specific interaction of reductively activated nitroimidazoles with DNA.
    Declerck PJ; De Ranter CJ; Volckaert G
    FEBS Lett; 1983 Nov; 164(1):145-8. PubMed ID: 6317437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of nitroimidazoles in model chemical and biological systems.
    Wardman P; Anderson RF; Clarke ED; Jones NR; Minchinton AI; Patel KB; Stratford MR; Watts ME
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):777-80. PubMed ID: 7050044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the action of nitroimidazole drugs. The products of nitroimidazole reduction.
    Knox RJ; Knight RC; Edwards DI
    Biochem Pharmacol; 1983 Jul; 32(14):2149-56. PubMed ID: 6870942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of 1-substituted 2-nitroimidazoles: effect of partition coefficient and side-chain hydroxyl groups on radiosensitization in vitro.
    Brown DM; Parker E; Brown JM
    Radiat Res; 1982 Apr; 90(1):98-108. PubMed ID: 7199747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroimidazoles as chemotherapeutic agents.
    Nair MD; Nagarajan K
    Prog Drug Res; 1983; 27():163-252. PubMed ID: 6361850
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiosensitizing ability and cytotoxicity of some 5(4)-substituted 2-methyl-4(5)-nitroimidazoles.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1982; 29(4):407-15. PubMed ID: 7133232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    Biochem Pharmacol; 1988 Jul; 37(13):2603-6. PubMed ID: 3390219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group.
    Boechat N; Carvalho AS; Salomão K; Castro SL; Araujo-Lima CF; Mello FV; Felzenszwalb I; Aiub CA; Conde TR; Zamith HP; Skupin R; Haufe G
    Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):492-9. PubMed ID: 26018452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours.
    Denekamp J; McNally NJ
    Br J Radiol; 1978 Sep; 51(609):747-8. PubMed ID: 698524
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA damage induced by reduced nitroimidazole drugs.
    Zahoor A; Lafleur MV; Knight RC; Loman H; Edwards DI
    Biochem Pharmacol; 1987 Oct; 36(19):3299-304. PubMed ID: 3663242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic and hypoxic toxicity of a new class of mixed-function drugs associating nitroimidazoles and chloroethylnitrosourea in nitrosourea-sensitive (Mer-) and -resistant (Mer+) human tumor cells.
    Mulcahy RT; Carminati A; Barascut JL; Imbach JL
    Cancer Res; 1988 Feb; 48(4):798-801. PubMed ID: 3338077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer.
    Anderson RF; Li D; Hunter FW
    Free Radic Biol Med; 2017 Dec; 113():564-570. PubMed ID: 29111232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the action of misonidazole. I. Effect of TAN on toxicity.
    Skov KA; Palcic B; Harrison IE; Skarsgard LD
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):601-11. PubMed ID: 6968295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.